Regional union selects dario's cardiometabolic solution for diabetes, hypertension, weight management and glp-1 support

Dario's integrated solution to support improved whole health gains traction in public and labor market new york , jan. 11, 2024 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today a new contract to provide its cardiometabolic solution to a regional union (the "union"), expected to begin in the first quarter of 2024.   the union, representing food industry workers, selected dario to deliver integrated support for employees living with diabetes, pre-diabetes and weight management needs along with special support for those taking a glp-1, or anti-obesity medication.
DRIO Ratings Summary
DRIO Quant Ranking